Articles

Resource Allocation for Colorectal Cancer Screening

By Naimish Pandya, MD

VBCC Perspectives

October 2010, Vol 1, No 5

As Economy Worsens, Financial Factors May Hinder CRC Screening

Colon Cancer, Economics & Value

October 2010, Vol 1, No 5

CRC Screening Economics: Diminishing Returns as Technology Advances?

Colon Cancer

October 2010, Vol 1, No 5

CMS-FDA Proposed Premarket Parallel Review—The Devil is in the Details

By Jayson Slotnik, JD, MPH

October 2010, Vol 1, No 5

Improving Health Economics Research

Economics & Value

October 2010, Vol 1, No 5

It is true that some branches of academic economics sometimes value theoretical insights and technical details over pragmatic results that can be broadly applied. However, most of the core insights of economic analysis tend to be accessible and have highly pragmatic implications.

Real-World Decision Makers Decry Information Provided

October 2010, Vol 1, No 5

Accelerated Approval: Good Intentions, Difficult Implementation

FDA Approvals, News & Updates

October 2010, Vol 1, No 5

Guiding Patients Through Cost-Based Treatment Choices

Patient Navigation, Policies & Guidelines

October 2010, Vol 1, No 5

Breast Cancer Screening Recommendations: Evidence, Fear, and Politics

By Michael K. Gusmano, PhD

Cancer Screening, Health Policy, Policies & Guidelines

October 2010, Vol 1, No 5